DOTA-tris(t-Butyl ester)

DOTA-tris(t-Butyl ester) is a high-purity pharmaceutical-intermediates supplied for industrial and specialty chemical applications. Contact our team for specifications, packaging options and lead times.

DOTA-tris(t-Butyl ester) is primarily used as a chelating agent precursor in the synthesis of metal complexes for biomedical and diagnostic applications. It serves as a key intermediate in the preparation of radiopharmaceuticals, including MRI contrast agents and targeted radiotherapy compounds. The t-butyl ester groups protect the carboxyl functionalities during multi-step organic synthesis, allowing for selective deprotection and subsequent conjugation with biomolecules, peptides, or targeting ligands in research and pharmaceutical development.

The compound offers several benefits, including chemical stability, ease of handling, and protection of reactive carboxyl groups during synthetic procedures. Its esterified form enables precise control over deprotection and metal chelation steps, improving the efficiency of radiopharmaceutical synthesis. DOTA-tris(t-Butyl ester) also contributes to enhanced solubility in organic solvents, facilitating multi-step reactions and enabling high-purity product formation. Its versatility supports the development of complex metal-chelate compounds for diagnostic imaging and therapeutic applications.

DOTA-tris(t-Butyl ester) is a valuable intermediate for the synthesis of metal-chelating agents in biomedical and pharmaceutical research. Its protected ester groups, chemical stability, and synthetic versatility make it essential for producing high-performance MRI contrast agents, radiopharmaceuticals, and other advanced metal-complex compounds, supporting innovation in medical diagnostics and targeted therapies.

Previous

2-Methylpiperazine丨CAS 109-07-9

Next

Diethyl Bromodifluoromethanephosphonate丨CAS 65094-22-6